Company Profiles

driven by the PitchBook Platform

Intervention Insights

Description

Provider of cancer therapeutic information services to assist community oncologists. The company analyzes cancerous tissues and generates a genomic picture of genes and corresponding molecular pathways helping oncology care team to access and consider medical evidence to support the molecular diagnostics and targeted therapeutics.

2009

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$3.5M

Latest Deal Amount

$13.2M

Total Amount Raised

Description

Provider of cancer therapeutic information services to assist community oncologists. The company analyzes cancerous tissues and generates a genomic picture of genes and corresponding molecular pathways helping oncology care team to access and consider medical evidence to support the molecular diagnostics and targeted therapeutics.

Website:

www.interventioninsights.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Information Services (B2C)

Other Industries

Other Healthcare Services

Primary Office

1601 Trapelo Road Suite 255 Cambridge, MA 02142United States +1 (617) 250-7572
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Intervention Insights's full profile, request a free trial.

Intervention Insights Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Intervention Insights Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Intervention Insights Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ann Arbor SPARKAccelerator/IncubatorMinority000 0000000 0000
BeringeaPE/BuyoutMinority000 0000000 0000
Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
Chrysalis VenturesVenture CapitalMinority000 0000000 0000
Hopen Life Science VenturesVenture CapitalMinority000 0000000 0000
Ann Arbor SPARK Accelerator/Incubator
Beringea PE/Buyout
Biosciences Research and Commercialization Center Venture Capital
Chrysalis Ventures Venture Capital
Hopen Life Science Ventures Venture Capital

Intervention Insights Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Dennis ReillyChief Financial Officer
Russell Ingersoll Ph.DChief Product Officer
Russ Clark JDVice President
Clynt TaylorChief Executive Officer & Board Member
Alex GinzburgVice President, Technology
Dennis Reilly Chief Financial Officer
Russell Ingersoll Ph.D Chief Product Officer
Russ Clark JD Vice President
Clynt Taylor Chief Executive Officer & Board Member
Alex Ginzburg Vice President, Technology

Intervention Insights Board Members (5)

NameRepresentingRoleSinceContact
Info
Charlie CrawfordChrysalis VenturesAssociate000 0000
Clynt TaylorSelfChief Executive Officer & Board Member000 0000
Mark OlesnavageHopen Life Science VenturesCo-Founder & Managing Director000 0000
Michael GrossBeringeaManaging Director000 0000
Wright SteenrodChrysalis VenturesPartner000 0000
Charlie Crawford Associate Chrysalis Ventures
Clynt Taylor Chief Executive Officer & Board Member Self
Mark Olesnavage Co-Founder & Managing Director Hopen Life Science Ventures
Michael Gross Managing Director Beringea
Wright Steenrod Partner Chrysalis Ventures
Request full access to PitchBook